Eli Lilly and Company News Releases https://investor.lilly.com/ Eli Lilly and Company News Releases en Lilly to Participate in Goldman Sachs Global Healthcare Conference https://investor.lilly.com/news-releases/news-release-details/lilly-participate-goldman-sachs-global-healthcare-conference-3 INDIANAPOLIS , May 30, 2019 /PRNewswire/ --  Eli Lilly and Company (NYSE: LLY) will participate in the Goldman Sachs 40 th Annual Global Healthcare Conference on Wednesday, June 12, 2019 . Joshua Smiley , senior vice president and Lilly's chief financial officer, will participate in a fireside chat Thu, 30 May 2019 16:15:00 -0400 Eli Lilly and Company News Releases 41376 Lilly Announces Webcast to Discuss ADA Presentations and Diabetes Portfolio https://investor.lilly.com/news-releases/news-release-details/lilly-announces-webcast-discuss-ada-presentations-and-diabetes INDIANAPOLIS , May 29, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will conduct a webcast on Monday, June 10, 2019 to discuss the company's diabetes portfolio and its presentations at the American Diabetes Association's 79th Scientific Sessions in San Francisco, California . Wed, 29 May 2019 16:15:00 -0400 Eli Lilly and Company News Releases 41371 Lilly to Participate in UBS Global Healthcare Conference https://investor.lilly.com/news-releases/news-release-details/lilly-participate-ubs-global-healthcare-conference-1 INDIANAPOLIS , May 16, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) will attend the UBS Global Healthcare Conference on Tuesday, May 21, 2019 . Christi Shaw , president of Lilly Bio-Medicines, will participate in a fireside chat at 9:30 a.m., Eastern Time. Thu, 16 May 2019 16:30:00 -0400 Eli Lilly and Company News Releases 41316 Lilly to Participate in Bank of America Merrill Lynch Health Care Conference https://investor.lilly.com/news-releases/news-release-details/lilly-participate-bank-america-merrill-lynch-health-care-1 INDIANAPOLIS , May 15, 2019 /PRNewswire/ --  Eli Lilly and Company (NYSE: LLY) will participate in the Bank of America Merrill Lynch 2019 Health Care Conference on Wednesday, May 15, 2019 . Enrique Conterno , senior vice president of Lilly and president of Lilly Diabetes and Lilly USA , will Wed, 15 May 2019 06:30:00 -0400 Eli Lilly and Company News Releases 41306 Lilly Declares Second-Quarter 2019 Dividend https://investor.lilly.com/news-releases/news-release-details/lilly-declares-second-quarter-2019-dividend INDIANAPOLIS , May 6, 2019 /PRNewswire/ -- The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the second quarter of 2019 of $0.645 per share on outstanding common stock. The dividend is payable June 10, 2019 , to shareholders of record at the close of business Mon, 06 May 2019 14:16:00 -0400 Eli Lilly and Company News Releases 41266 Lilly Reports Solid First-Quarter 2019 Financial Results, Updates 2019 Guidance to Reflect Disposition of Elanco Animal Health https://investor.lilly.com/news-releases/news-release-details/lilly-reports-solid-first-quarter-2019-financial-results-updates - Revenue in the first quarter of 2019 grew 3 percent, driven by 7 percent volume growth. Key growth products launched since 2014, including Trulicity, Taltz, Verzenio, Basaglar, Olumiant, Jardiance, Cyramza and Emgality represented approximately 39 percent of revenue and delivered strong volume Tue, 30 Apr 2019 06:25:00 -0400 Eli Lilly and Company News Releases 41221 Lilly Confirms Date and Conference Call for First-Quarter 2019 Financial Results Announcement https://investor.lilly.com/news-releases/news-release-details/lilly-confirms-date-and-conference-call-first-quarter-2019 INDIANAPOLIS , April 10, 2019 /PRNewswire/ --  Eli Lilly and Company (NYSE: LLY) will announce its first-quarter 2019 financial results on Tuesday, April 30, 2019 . Lilly will also conduct a conference call on that day with the investment community and media to further detail the company's Wed, 10 Apr 2019 16:30:00 -0400 Eli Lilly and Company News Releases 41121 Lilly to Participate in Barclays Global Healthcare Conference https://investor.lilly.com/news-releases/news-release-details/lilly-participate-barclays-global-healthcare-conference-2 INDIANAPOLIS , March 8, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) will participate in the Barclays Global Healthcare Conference on Wednesday, March 13, 2019 . Daniel Skovronsky , M.D., Ph.D., Lilly's Chief Scientific Officer and President of Lilly Research Laboratories , will Fri, 08 Mar 2019 07:30:00 -0500 Eli Lilly and Company News Releases 40946 Lilly to Participate in Cowen Health Care Conference https://investor.lilly.com/news-releases/news-release-details/lilly-participate-cowen-health-care-conference-0 INDIANAPOLIS , March 7, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) will participate in the Cowen and Company 39 th Annual Health Care Conference on Monday, March 11, 2019 . Joshua Smiley , senior vice president and Lilly's chief financial officer, will participate in a fireside chat at Thu, 07 Mar 2019 17:15:00 -0500 Eli Lilly and Company News Releases 40936 Lilly To Participate in Leerink Partners Global Healthcare Conference https://investor.lilly.com/news-releases/news-release-details/lilly-participate-leerink-partners-global-healthcare-conference INDIANAPOLIS , Feb. 14, 2019 /PRNewswire/ --  Eli Lilly and Company (NYSE: LLY) will participate in the Leerink Partners Global Healthcare Conference on Wednesday, February 27, 2019 . Christi Shaw , president of Lilly Bio-Medicines, will participate in a fireside chat at 1:00 p.m., Eastern Time. Thu, 14 Feb 2019 16:30:00 -0500 Eli Lilly and Company News Releases 40661 Lilly to Participate in Guggenheim Healthcare Talks Idea Forum https://investor.lilly.com/news-releases/news-release-details/lilly-participate-guggenheim-healthcare-talks-idea-forum INDIANAPOLIS , Feb. 8, 2019 /PRNewswire/ --  Eli Lilly and Company (NYSE:LLY) will participate in the Guggenheim Healthcare Talks Idea Forum on Thursday, February 14, 2019 . Anne White , president of Lilly Oncology, and Levi Garraway , M.D., Ph.D., senior vice president, oncology research and Fri, 08 Feb 2019 13:00:00 -0500 Eli Lilly and Company News Releases 40536 Lilly Reports Strong Fourth-Quarter and Full-Year 2018 Financial Results, Lowers 2019 EPS Guidance to Reflect the Pending Acquisition of Loxo Oncology https://investor.lilly.com/news-releases/news-release-details/lilly-reports-strong-fourth-quarter-and-full-year-2018-financial - Fourth-quarter 2018 revenue increased 5 percent, driven by increased demand for newer medicines, while operating expenses increased 1 percent. Full-year 2018 revenue increased 7 percent to $24.556 billion. - Fourth-quarter 2018 earnings per share (EPS) grew to $1.10 on a reported basis, or $1.33 Wed, 06 Feb 2019 06:25:00 -0500 Eli Lilly and Company News Releases 40401 Lilly Revises Date for Fourth-Quarter 2018 Financial Results Announcement https://investor.lilly.com/news-releases/news-release-details/lilly-revises-date-fourth-quarter-2018-financial-results INDIANAPOLIS , Jan. 30, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) has revised the date for its fourth-quarter and full-year 2018 financial results announcement. The company will now announce results on Wednesday, February 6, 2019 , one week earlier than previously scheduled. Wed, 30 Jan 2019 15:15:00 -0500 Eli Lilly and Company News Releases 40261 Lilly Confirms Date and Conference Call for Fourth-Quarter 2018 Financial Results Announcement https://investor.lilly.com/news-releases/news-release-details/lilly-confirms-date-and-conference-call-fourth-quarter-2018 INDIANAPOLIS , Jan. 21, 2019 /PRNewswire/ --  Eli Lilly and Company (NYSE: LLY) will announce its fourth-quarter and full-year 2018 financial results on Wednesday, February 13, 2019 . Lilly will also conduct a conference call on that day with the investment community and media to further detail the Mon, 21 Jan 2019 16:15:00 -0500 Eli Lilly and Company News Releases 40221 Lilly to Participate in J.P. Morgan Healthcare Conference https://investor.lilly.com/news-releases/news-release-details/lilly-participate-jp-morgan-healthcare-conference INDIANAPOLIS , Jan. 3, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will participate in the 37 th Annual J.P. Morgan Healthcare Conference on Tuesday, January 8, 2019 . David A. Ricks , Lilly's chairman and chief executive officer, will participate in a fireside chat from 6:00 p.m. Thu, 03 Jan 2019 16:30:00 -0500 Eli Lilly and Company News Releases 40126 Lilly Announces Financial Guidance, Reviews Commercial Performance, and Highlights Promising Pipeline Opportunities at Investment Community Meeting https://investor.lilly.com/news-releases/news-release-details/lilly-announces-financial-guidance-reviews-commercial INDIANAPOLIS , Dec. 19, 2018 /PRNewswire/ -- 2019 revenue is expected to be between $25.3 billion and $25.8 billion , representing mid-single-digit growth driven by volume from newer medicines, including Trulicity, Taltz, Basaglar, Jardiance, Verzenio, Cyramza, Olumiant and Lartruvo, as well as the Wed, 19 Dec 2018 06:30:00 -0500 Eli Lilly and Company News Releases 40081 Lilly Announces 15 Percent Dividend Increase https://investor.lilly.com/news-releases/news-release-details/lilly-announces-15-percent-dividend-increase INDIANAPOLIS , Dec. 19, 2018 /PRNewswire/ -- The board of directors of Eli Lilly and Company (NYSE: LLY) today announced a 15 percent increase in its quarterly dividend. The dividend for the first quarter of 2019 will be $0.645 per share on outstanding common stock. Wed, 19 Dec 2018 06:25:00 -0500 Eli Lilly and Company News Releases 40076 Lilly to Announce 2019 Financial Guidance, Highlight Late-Stage Pipeline Opportunities and Discuss Commercial Performance at Upcoming Investment Community Meeting https://investor.lilly.com/news-releases/news-release-details/lilly-announce-2019-financial-guidance-highlight-late-stage INDIANAPOLIS , Nov. 27, 2018 /PRNewswire/ --  Eli Lilly and Company (NYSE:LLY) today announced that it will host a meeting for the investment community on Wednesday, December 19, 2018 , from 9:00 a.m. (EST) until approximately 12:00 p.m. Earlier that day, the company will announce its financial Tue, 27 Nov 2018 06:30:00 -0500 Eli Lilly and Company News Releases 39956 Lilly to Participate in Credit Suisse 27th Annual Healthcare Conference https://investor.lilly.com/news-releases/news-release-details/lilly-participate-credit-suisse-27th-annual-healthcare INDIANAPOLIS , Nov. 8, 2018 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will participate in the Credit Suisse 27 th Annual Healthcare Conference on Tuesday, November 13, 2018 . Enrique Conterno , senior vice president of Lilly and president of Lilly Diabetes and Lilly USA , will participate Thu, 08 Nov 2018 16:30:00 -0500 Eli Lilly and Company News Releases 39861 Lilly Delivers Solid Third-Quarter 2018 Results, Revises EPS Guidance https://investor.lilly.com/news-releases/news-release-details/lilly-delivers-solid-third-quarter-2018-results-revises-eps - Third-quarter 2018 revenue increased 7 percent, driven primarily by increased demand for new medicines, while operating expenses increased 1 percent. - Third-quarter 2018 earnings per share (EPS) grew to $1.12 (reported), and $1.39 (non-GAAP). - Pharmaceutical revenue in the third quarter of 2018 Tue, 06 Nov 2018 06:25:00 -0500 Eli Lilly and Company News Releases 39826 Lilly Declares Fourth-Quarter 2018 Dividend https://investor.lilly.com/news-releases/news-release-details/lilly-declares-fourth-quarter-2018-dividend INDIANAPOLIS , Oct. 15, 2018 /PRNewswire/ -- The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the fourth quarter of 2018 of $0.5625 per share on outstanding common stock. The dividend is payable December 10, 2018 , to shareholders of record at the close of Mon, 15 Oct 2018 13:57:00 -0400 Eli Lilly and Company News Releases 39731 Lilly Confirms Date and Conference Call for Third-Quarter 2018 Financial Results Announcement https://investor.lilly.com/news-releases/news-release-details/lilly-confirms-date-and-conference-call-third-quarter-2018 INDIANAPOLIS , Oct. 3, 2018 /PRNewswire/ --  Eli Lilly and Company (NYSE: LLY) will announce its financial results for the third quarter of 2018 on Tuesday, November 6, 2018 . Lilly will also conduct a conference call on that day with the investment community and media to further detail the Wed, 03 Oct 2018 15:00:00 -0400 Eli Lilly and Company News Releases 39661 Lilly Announces Webcast to Discuss EASD Presentations https://investor.lilly.com/news-releases/news-release-details/lilly-announces-webcast-discuss-easd-presentations INDIANAPOLIS , Sept. 6, 2018 /PRNewswire/ --  Eli Lilly and Company (NYSE: LLY) will conduct a webcast on Thursday, October 4, 2018 to discuss the company's presentations at the 54 th annual meeting of the European Association for the Study of Diabetes (EASD) in Berlin, Germany . Thu, 06 Sep 2018 07:00:00 -0400 Eli Lilly and Company News Releases 39466 Lilly to Participate in Morgan Stanley Global Healthcare Conference https://investor.lilly.com/news-releases/news-release-details/lilly-participate-morgan-stanley-global-healthcare-conference-2 INDIANAPOLIS , Aug. 27, 2018 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) will attend the Morgan Stanley Global Healthcare Conference on Wednesday, September 12, 2018 . Joshua Smiley , senior vice president and Lilly's chief financial officer, will participate in a fireside chat at 1:40 p.m., Mon, 27 Aug 2018 16:30:00 -0400 Eli Lilly and Company News Releases 39426 Lilly Delivers Strong Second-Quarter 2018 Results, Revises EPS Guidance https://investor.lilly.com/news-releases/news-release-details/lilly-delivers-strong-second-quarter-2018-results-revises-eps - Second-quarter 2018 revenue increased 9 percent, driven primarily by the increased demand for new pharmaceutical products, while operating expenses declined. - Second-quarter 2018 earnings per share (EPS) were a loss of $0.25 on an as-reported basis, primarily due to charges related to recent Tue, 24 Jul 2018 06:25:00 -0400 Eli Lilly and Company News Releases 39281 Lilly Confirms Date and Conference Call for Second-Quarter 2018 Financial Results Announcement https://investor.lilly.com/news-releases/news-release-details/lilly-confirms-date-and-conference-call-second-quarter-2018 INDIANAPOLIS , June 28, 2018 /PRNewswire/ --  Eli Lilly and Company (NYSE: LLY) will announce its financial results for the second quarter of 2018 on Tuesday, July 24, 2018 . Lilly will also conduct a conference call on that day with the investment community and media to further detail the Thu, 28 Jun 2018 16:30:00 -0400 Eli Lilly and Company News Releases 39186 Lilly Declares Third-Quarter 2018 Dividend https://investor.lilly.com/news-releases/news-release-details/lilly-declares-third-quarter-2018-dividend INDIANAPOLIS , June 18, 2018 /PRNewswire/ -- The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the third quarter of 2018 of $0.5625 per share on outstanding common stock. The dividend is payable September 10, 2018 , to shareholders of record at the close of Mon, 18 Jun 2018 16:27:00 -0400 Eli Lilly and Company News Releases 39091 Lilly to Participate in Goldman Sachs Global Healthcare Conference https://investor.lilly.com/news-releases/news-release-details/lilly-participate-goldman-sachs-global-healthcare-conference-2 INDIANAPOLIS , May 31, 2018 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will participate in the Goldman Sachs 39 th Annual Global Healthcare Conference on Wednesday, June 13, 2018 . David A. Ricks , Lilly's chairman and chief executive officer, will participate in a fireside chat at 1:00 Thu, 31 May 2018 17:00:00 -0400 Eli Lilly and Company News Releases 38986 Lilly to Participate in Jefferies Global Healthcare Conference https://investor.lilly.com/news-releases/news-release-details/lilly-participate-jefferies-global-healthcare-conference INDIANAPOLIS , May 30, 2018 /PRNewswire/ --  Eli Lilly and Company (NYSE: LLY) will attend the Jefferies Global Healthcare Conference on Wednesday, June 6, 2018 . Joshua Smiley , senior vice president and Lilly's chief financial officer, will participate in a fireside chat at 11:00 a.m., Eastern Wed, 30 May 2018 17:21:00 -0400 Eli Lilly and Company News Releases 38971 Lilly to Participate in UBS Global Healthcare Conference https://investor.lilly.com/news-releases/news-release-details/lilly-participate-ubs-global-healthcare-conference-0 INDIANAPOLIS , May 11, 2018 /PRNewswire/ --  Eli Lilly and Company (NYSE:LLY) will attend the UBS Global Healthcare Conference on Tuesday, May 22, 2018 . Enrique Conterno , senior vice president of Lilly and president of Lilly Diabetes and Lilly USA , will participate in a fireside chat at Fri, 11 May 2018 13:00:00 -0400 Eli Lilly and Company News Releases 38891